Bio-Rad Laboratories | BIO

Stock Price
295.43
Daily Change
6.00 2.07%
Monthly
11.77%
Yearly
-10.48%
Q3 Forecast
292.98

Peers Price Chg Day Year Date
Tosoh 2,351.50 18.50 0.79% 26.73% Sep/05
Agilent 128.75 0.27 0.21% -6.04% Sep/05
Abbott 132.94 0.13 0.10% 16.68% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Bio-Rad Laboratories 295.43 6.00 2.07% -10.48% Sep/05
Bruker 30.83 1.04 3.49% -51.84% Sep/05
Charles River Laboratories 163.99 1.68 1.04% -12.63% Sep/05
Quest Diagnostics 183.49 3.38 1.88% 20.12% Sep/05
Danaher 200.21 1.18 0.59% -24.77% Sep/05
Exact Sciences 53.81 2.40 4.67% -8.97% Sep/05
Standard Biotools 1.30 0.01 0.78% -32.99% Sep/05
General Electric Aerospace 279.23 -3.04 -1.08% 73.26% Sep/05
Hologic 66.76 0.37 0.56% -18.16% Sep/05
Illumina 98.93 1.25 1.28% -20.47% Sep/05
IQVIA Holdings 187.68 3.60 1.96% -22.83% Sep/05
Laboratory Of America 278.67 3.44 1.25% 24.30% Sep/05
Merck 84.71 0.66 0.79% -28.14% Sep/05
Mettler Toledo International 1,305.71 17.92 1.39% -5.26% Sep/05
Myriad Genetics 6.61 -0.18 -2.65% -75.49% Sep/05
Revvity 86.64 0.94 1.10% -24.90% Sep/05
Repligen 124.56 3.98 3.30% -15.31% Sep/05
Roche Holding 274.20 -1.50 -0.54% 2.62% Sep/06
Siemens 226.00 -4.05 -1.76% 38.99% Sep/06
Bio Techne 54.41 1.49 2.82% -24.00% Sep/05
Thermo Fisher Scientific 492.60 3.11 0.64% -19.59% Sep/05
Waters 306.32 6.63 2.21% -6.72% Sep/05


Bio-Rad Laboratories traded at $295.43 this Friday September 5th, increasing $6.00 or 2.07 percent since the previous trading session. Looking back, over the last four weeks, Bio-Rad Laboratories gained 11.77 percent. Over the last 12 months, its price fell by 10.48 percent. Looking ahead, we forecast Bio-Rad Laboratories to be priced at 292.98 by the end of this quarter and at 285.74 in one year, according to Trading Economics global macro models projections and analysts expectations.

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets approximately 6,000 reagents, apparatus and laboratory instruments. Its products are used in research techniques, biopharmaceutical production processes and food testing regimes. Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market.